Investigating Asthma After Coccidioidomycosis Among Patients With Commercial Health Insurance, United States, 2017-2022.

IF 3.1 2区医学 Q1 DERMATOLOGY Mycoses Pub Date : 2025-02-01 DOI:10.1111/myc.70033

Kaitlin Benedict, Dallas J Smith, Angela Haczku, Amir A Zeki, Joy Hsu, Mitsuru Toda, Nicholas J Kenyon, George R Thompson

{"title":"Investigating Asthma After Coccidioidomycosis Among Patients With Commercial Health Insurance, United States, 2017-2022.","authors":"Kaitlin Benedict, Dallas J Smith, Angela Haczku, Amir A Zeki, Joy Hsu, Mitsuru Toda, Nicholas J Kenyon, George R Thompson","doi":"10.1111/myc.70033","DOIUrl":null,"url":null,"abstract":"Background: The relationship between asthma and coccidioidomycosis has not been fully described. We have hypothesised that Coccidioides could trigger inflammatory airway responses, similar to other fungi.Objectives: To estimate the frequency of new-onset asthma-related symptoms after coccidioidomycosis and identify potentially associated factors.Patients/methods: We used a large health insurance claims database to identify patients with coccidiomycosis with and without an asthma diagnosis code or a short-acting β2 agonist prescription in the year after diagnosis.Results: Thirteen per cent of 1657 patients with an asthma diagnosis code or a short-acting β2 agonist prescription (median 2.5 months later).Conclusions: Increased healthcare provider awareness of asthma as a potential coccidioidomycosis complication could benefit patients, especially female patients and patients with severe pulmonary infection.","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"68 2","pages":"e70033"},"PeriodicalIF":3.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182640/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mycoses","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/myc.70033","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The relationship between asthma and coccidioidomycosis has not been fully described. We have hypothesised that Coccidioides could trigger inflammatory airway responses, similar to other fungi.

Objectives: To estimate the frequency of new-onset asthma-related symptoms after coccidioidomycosis and identify potentially associated factors.

Patients/methods: We used a large health insurance claims database to identify patients with coccidiomycosis with and without an asthma diagnosis code or a short-acting β₂ agonist prescription in the year after diagnosis.

Results: Thirteen per cent of 1657 patients with an asthma diagnosis code or a short-acting β₂ agonist prescription (median 2.5 months later).

Conclusions: Increased healthcare provider awareness of asthma as a potential coccidioidomycosis complication could benefit patients, especially female patients and patients with severe pulmonary infection.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

美国商业健康保险患者球虫菌病后哮喘调查，2017-2022。

背景：哮喘与球孢子菌病之间的关系尚未得到充分的描述。我们假设球虫可以像其他真菌一样引发气道炎症反应。目的：估计球虫菌病后新发哮喘相关症状的频率，并确定潜在的相关因素。患者/方法：我们使用一个大型健康保险索赔数据库来识别球虫菌病患者，诊断后一年内有或没有哮喘诊断代码或短效β2激动剂处方。结果：1657例哮喘诊断代码或短效β2激动剂处方的患者中有13%（中位2.5个月后）。结论：提高医护人员对哮喘作为一种潜在球孢子菌病并发症的认识，可以使患者受益，特别是女性患者和严重肺部感染患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Mycoses 医学-皮肤病学

CiteScore

10.00

自引率

8.20%

发文量

143

审稿时长

6-12 weeks

期刊介绍： The journal Mycoses provides an international forum for original papers in English on the pathogenesis, diagnosis, therapy, prophylaxis, and epidemiology of fungal infectious diseases in humans as well as on the biology of pathogenic fungi. Medical mycology as part of medical microbiology is advancing rapidly. Effective therapeutic strategies are already available in chemotherapy and are being further developed. Their application requires reliable laboratory diagnostic techniques, which, in turn, result from mycological basic research. Opportunistic mycoses vary greatly in their clinical and pathological symptoms, because the underlying disease of a patient at risk decisively determines their symptomatology and progress. The journal Mycoses is therefore of interest to scientists in fundamental mycological research, mycological laboratory diagnosticians and clinicians interested in fungal infections.